Alternative Finance Market expected to grow by USD 64.3 Billion from 2024-2028, driven by AI’s impact and the rise of social media and digital connectivity – Technavio
NEW YORK, Oct. 14, 2024 /PRNewswire/ — Report with market evolution powered by AI – The Global Alternative Finance Market size is estimated to grow by USD 64.3 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 7.44% during the forecast
New Minimum Gasoline Reserve Law Will Prevent CA Gasoline Prices Spikes And Should Be A Bellwether For Nation, Consumer Watchdog Says
SACRAMENTO, Calif., Oct. 14, 2024 /PRNewswire/ — Consumer Watchdog hailed Governor Newsom’s signing today of California’s new gasoline minimum inventory law, ABX2-1, as a pivotal moment in the fight against California gas spikes and called on other states to follow suit with simila
Medical Device Packaging Market in Europe projected to grow by USD 4.89 billion from 2024-2028, driven by AI’s impact and rising demand for medical devices – Technavio
NEW YORK, Oct. 14, 2024 /PRNewswire/ — Report on how AI is redefining market landscape – The Medical Device Packaging Market in Europe size is estimated to grow by USD 4.89 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 8.89% duri
Tri-City Healthcare District Provides Notice of Data Incident
SAN DIEGO, Oct. 14, 2024 /PRNewswire/ — Tri-City Healthcare District (“Tri-City”) announces a data incident that impacted some protected health information stored on its network. On November 9, 2023, Tri-City detected suspicious activity on its network and immediately began an inve
Automation Solutions for Renewable Power Generation Market expected to grow by USD 3.15 Billion from 2024-2028 driven by AI-powered advancements and supportive renewable policies – Technavio
NEW YORK, Oct. 14, 2024 /PRNewswire/ — Report on how AI is driving market transformation – The Global Automation Solutions for Renewable Power Generation Market size is estimated to grow by USD 3.15 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Longboard Pharmaceuticals, Inc.
NEW YORK, Oct. 14, 2024 /PRNewswire/ — Rowley Law PLLC is investigating potential securities law violations by Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) and its board of directors concerning the proposed acquisition of the company by H. Lundbeck A/S. Stockholders will receive $60.00 for e
CPAP Devices Market projected to grow by USD 1.33 Billion from 2024-2028 fueled by AI’s role in addressing sleep apnea and respiratory disorders – Technavio
NEW YORK, Oct. 14, 2024 /PRNewswire/ — Report with market evolution powered by AI – The Global Continuous Positive Airway Pressure (CPAP) Devices Market size is estimated to grow by USD 1.33 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of ab
Katten Recognized for DEI Efforts With Mansfield Certified Plus Designation
CHICAGO, Oct. 14, 2024 /PRNewswire/ — Katten announced today that the firm earned the Mansfield Rule Certified Plus designation for its efforts to ensure a broad slate of attorneys continues to be considered for leadership roles and that advancement opportunities across the firm are inclusive.
Kodiak Sciences to Present at Innovate Retina 2024
PALO ALTO, Calif., Oct. 14, 2024 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today its participation in a presentatio
CDK4/6 Inhibitors Market to Grow at Healthy Growth Rate by 2034 Owing to Expanded Usage of Approved Blockbuster CDK4/6 Inhibitors in Early-stage Breast Cancer and the Emergence of Newer Players in Other Indications | DelveInsight
The CDK4/6 inhibitors market is expected to grow significantly in the coming years. This is mainly due to the increasing incidence of HR+/HER2 breast cancer, the type for which CDK4/6 inhibitors are majorly prescribed. CDK4/6 inhibitors are now an established class, with all three approved CDK4/6 i
